A functional polymorphism of the tumor necrosis factor receptor-II gene associated with the survival and relapse prediction of breast carcinoma

Cytokine

Volumn 30, Issue 4, 2005, Pages 182-187

  Mestiri, Souhir ^a   Bouaouina, Noureddine ^a,b   Ahmed, Slim Ben ^c   Chouchane, Lotfi ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b Dept of Cancerol Radiotherapie ^*  (Tunisia)

^c FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

Breast carcinoma; Polymorphism; Prognosis; Susceptibility; TNF receptor; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ALLELE; ARTICLE; BREAST CARCINOMA; CANCER RELAPSE; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION MAPPING; TUMOR NECROSIS FACTOR RECEPTOR II GENE;

EID: 18144365537     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2005.01.007     Document Type: Article

References (38)

1. F. Bazzoni, and B. Beutler The tumor necrosis factor ligand and receptor families N Engl J Med 334 1996 1717 1725
2. E.A. Carswell, L.J. Old, S. Green, N. Fiore, and B. Williamson An endotoxin-induced serum factor that causes necrosis of tumors Proc Natl Acad Sci U S A 2 1975 3666 3670
3. G. Salles, J. Bienvenu, Y. Bastion, Y. Barbier, C. Doche, and K. Warzocha Elevated circulating levels of TNF-α and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients Br J Haematol 93 1996 352 359
4. K. Warzocha, G. Salles, J. Bienvenu, Y. Bastion, C. Dumontet, and N. Renard The tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients J Clin Oncol 15 1997 499 508
5. K.J. Tracey, H. Wei, K.R. Manogue, Y. Fong, D.G. Hess, and H.T. Nguyen Cachectin/tumor necrosis factor induces cachexia, anemia and inflammation J Exp Med 167 1988 1211 1227
6. K.J. Tracey TNF and Mae West or: death from too much of a good thing Lancet 345 1995 75 76
7. A. Gadducci, M. Ferdeghini, C. Castellani, C. Annicchiarico, O. Gagetti, and C. Prontera Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer Gynecol Oncol 58 1995 184 188
8. R. Partanen, H. Koskinen, and K. Hemminki Tumor necrosis factor-alpha (TNF-alpha) in patients who have asbestosis and develop cancer Occup Environ Med 52 1995 316 319
9. T. Himeno, N. Watanabe, N. Yamauchi, M. Maeda, Y. Tsuji, and T. Okamoto Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor Cancer Res 50 1990 4941 4945
10. T. Okamoto, N. Watanabe, N. Yamauchi, N. Tsuji, Y. Itoh, and H. Neda Endogenous tumor necrosis factor exert its protective function intracellularly against the cytotoxicity of exogenous tumor necrosis factor Cancer Res 52 1992 5278 5281
11. Y. Tsuji, N. Watanabe, T. Okamoto, N. Tsuji, H. Sasaki, and S. Akiyama Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity Cancer Res 52 1992 6258 6262
12. H. Fujiki, A. Komori, and J. Yatsunami Tumor necrosis factor as an endogenous tumor promotor Proc Am Assoc Cancer Res 34 1993 180
13. H. Fujiki, M. Suganuma, A. Komori, J. Yatsunami, S. Okabe, and T. Ohta A new tumor promotion pathway and its inhibitors Cancer Detect Prev 18 1994 1 7
14. C.F. Ware, T.L. VanArsdale, P.D. Crowe, and J.L. Browning The ligands and receptors of the lymphotoxin system Curr Top Microbiol Immunol 198 1995 175 218
15. S.M. Santee, and L.B. Owen-Schaub Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization J Biol Chem 271 35 1996 21151 21159
16. P. Pantelidis, P.A. Lympany, P.J. Foley, G.C. Fanning, K.I. Welsh, and R.M. Du Bois Polymorphic analysis of the high-affinity tumor necrosis factor receptor 2 Tissue Antigens 54 1999 585 591
17. C.P. Beltinger, P.S. White, J.M. Maris, E.P. Sulman, S.J. Jensen, and D. LePaslier Physical mapping and genomic structure of the human TNFR2 gene Genomics 35 1996 94 100
18. D. Aderka, H. Engelmann, Y. Maor, C. Brakebusch, and D. Wallach Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors J Exp Med 175 1992 323 329
19. N.M. Hooper, E.H. Karran, and A.J. Turner Membrane protein secretases Biochem J 15 1997 265 279
20. C. Morita, T. Horiuchi, H. Tsukamoto, N. Hatta, Y. Kikuchi, and Y. Arinobu Association of tumor necrosis factor receptor type II polymorphism 196R with systemic lupus erythematosus in the Japanese. Molecular and functional analysis Arthritis Rheum 44 12 2001 2819 2827
21. S. Mestiri, N. Bouaouina, S. Ben Ahmed, A. Khedhaier, B. Belhadj Jrad, and S. Remadi Genetic variation in the Tumor Necrosis Factor-α promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma Cancer 91 4 2001 672 678
22. L. Trentin, R. Zambello, P. Bulian, A. Cerutti, C. Enthammer, and M. Cassatella Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor Br J Cancer 71 1995 240 245
23. A.T. Mason, R.D. Mcvica, C.A. Smith, H.A. Young, C.F. Ware, and J.R. Ortaldo Regulation of NK cells through the 80 kDa TNFR (CD120b) J Leukoc Biol 58 1995 249 255
24. G. Gehr, R. Gentz, M. Brockhaus, H. Loetscher, and W. Lesslauer Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation J Immunol 149 1992 911 917
25. P. Vandenabeele, W. Declercq, D. Vercammen, M. Van de Craen, J. Grooten, and H. Loetscher Functional characterization of the human tumor necrosis receptor p75 in a transfected rat/mouse T cell hybridoma J Exp Med 176 1992 1015 1024
26. S.L. Erickson, F.J. de Sauvage, K. Kikly, K. Carver-Moore, S. Pitts-Meek, and N. Gillett Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice Nature 372 1994 560 563
27. I. Garcia, Y. Miyazaki, K. Araki, M. Araki, R. Lucas, and G.E. Grau Transgenic mice expressing high-levels of soluble TNFRI fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania-major infections Eur J Immunol 25 1995 2401 2407
28. L. Trentin, R. Zambello, C. Agostini, F. Siviero, F. Adami, and R. Marcolongo Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders Blood 81 3 1993 752 758
29. J.L. Welborn, J.P. Lewis, H. Jenks, and P. Walling Diagnostic and prognostic significance of t(1;3) (p36, q21) in the disorders of hematopoiesis Cancer Genet Cytogenet 28 1987 277 285
30. G.R. Cambrin, C. Mecucci, A. VanOrshoven, G. Tricot, and H. Van den Berghe Translocation t(1, 3) (p36,q21) in malignant myeloid stem cell disorders Cancer Genet Cytogenet 22 1986 75 81
31. D.J. Moir, P.A.E. Jones, J. Pearson, J.R. Duncan, P. Cook, and V.J. Buckle A new translocation t(1;3) (p36, q21) in myelodysplastic disorders Blood 64 1984 553 555
32. C.D. Bloomfield, O.M. Garson, L. Volin, S. Knuutila, and A. de la Chapelle t(1;3) (p36,q21) in acute non lymphocytic leukaemia: a new cytogenetic-clinicopathologic association Blood 66 1985 1409 1413
33. K. Yamada, E. Sugimoto, M. Amano, Y. Imamura, T. Kubota, and M. Matsumoto Two cases of acute promyelocytic leukemia with variant translocations: the importance of chromosome No 17 abnormality Cancer Genet Cytogenet 9 1983 93 99
34. A. Weith, G.M. Brodeur, G.A.P. Bruns, T. Cox Matise, D. Mischke, and D. Nizetic Report of the second international workshop on human chromosome 1 mapping 1995 Cytogenet Cell Genet 72 1996 113 154
35. O. Olerup, and H. Zetterquist HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation Tissue Antigens 39 1992 225 235
36. A.S. Al-Ansari, W.E.R. Ollier, J. Villarreal, J. Ordi, L.S. Teh, and A.H. Hajeer Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus Tissue Antigens 55 2000 97 99
37. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
38. R. Peto, M.C. Pike, P. Armitage, N.E. Breslow, D.R. Cox, and S.V. Howard Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples Br J Cancer 35 1976 1 39